18
WELCOME EXPERIENCE PHARMACY AT KING’S

WELCOME EXPERIENCE PHARMACY AT KING’S. Timetable 12:00Introduction 12:15Mini-lectures: Medicines Optimisation |The Science Perspective |The Clinical Perspective

Embed Size (px)

Citation preview

WELCOME

EXPERIENCE PHARMACY AT KING’S

Timetable

12:00 Introduction12:15 Mini-lectures:

Medicines Optimisation |The Science Perspective |The Clinical Perspective

13:00 Lunch13:20 Practical work:

Medicines quality, consultation skills14:30 St Thomas’ Hospital:

Clinical orientation15:45 Unanswered questions

THE MPHARM PROGRAMME AT KING’S COLLEGE LONDON

PROFESSOR GRAHAM DAVIESProgramme Director

You will join a culture and tradition where…• Integrated teaching and

learning is the norm• Research informed teaching

is the norm• Excellent access to clinical

environment and high quality clinical teaching

• Challenge our students to be the best they can be

• High expectations of our students– International projects– “Ask Your Pharmacist” week– 80% graduate with 2:1 or

above

Course philosophy

“Science Transforming Healthcare”

To produce graduates who can apply the principles of science to ensure the optimal use of medicines by the patient, the public, healthcare professionals and society.

A programme producing graduates who:1. Make appropriate clinical judgements

when faced with complex, uncertain and ambiguous situations.

2. Possess a depth of pharmaceutical knowledge to resolve medicines related problems.

3. Use their research skills to underpin their practice

4. Adapt their learning to respond to work independently or as part of a multi-professional team.

5. Adopt and develop patient facing values

6. Show empathy to patients, carers and colleagues and accommodate difference

COURSE STRUCTURE

Overview of MPharm Integration

Chemistry ofDrugs

Nervous System

Respiratory &Musculoskeletal

Clinical Decision Making

Gastrointestinal & Skin

Cardiovascular & Renal

PhysicalPharmaceutics

Principles ofClinical Care

Biochemical Basis of

Therapeutics

Infection & Pharmaceutical

Microbiology

Endocrine & Cancer

Formulation & Analysis

Drugs

Emerging Therapies & Modern Medicines

Medicines Discovery &

Development

Research Project

Vertical Integration:

Applying knowledge and

skills to optimise medicines use.

Become a competent clinician.

Cardiovascular & Renal SystemModule – Year 2

Communicate effectively with the

patient

Understand the normal functions of

the kidneyUnderstand the disease

processes behind renal disease and assessment of renal

functionUnderstand drug design

from discovery to formulation

Therapeutic Options to treat renal disease

Be able to describe the pharmacology of

each of the drugs

Work effectively with other healthcare

professionals in the management of this

patient

Evaluate the patients treatment and be able to

identify problems and solutions

Understand the side effects, dosing profile

and monitoring aspects

Teaching Methods

1. Traditional lectures, practical classes, tutorials and symposia

2. Inter-professional learning

3. Simulation exercises• Forum theatre with patients• Reviewing prescribed therapy• Patient safety

4. Extensive placements experience

5. Student-led sessions• Clinical reasoning tutorials• Ethical debate – complex care decisions

Assessment

1. Variety of approaches

2. Extensive use of clinical examinations

3. Integrated examination papers

4. Focus preparing students for pre-registration experience

5. Range of innovative approaches

Clinical Reasoning Tutorials- Years 2-4• Interpretation of clinical

information– Biochemistry– Signs & symptoms– Cardiac tests

• Use of evidence based guidance(NICE)

• Application of a clinical problem solving framework

• Taught by clinical academic staff – Guy’s & St Thomas,– King’s College Hospital– Maudsley Hospital

Emerging Therapeutics & Modern Medicines – Year 4 – The DebateResearch scientific and ethical evidence to support both the pro and contra positions for their allocated clinical reasoning scenario; present written report and a group defence of either the pro- or contra-stance in the Pharmacy Debate

Example scenarios:

You are a consultant pharmacist working on a neurology ward and have a recently admitted patient suffering Lambert Eaton Myasthenic Syndrome. One of the attending medical team has suggested treatment with the licensed product, Firdapse, while another has suggested use of unlicensed tablets of amifampridine base.

Pro: Your team argue that the patient should be treated with Firdapse.

Contra: Your team argue that the patient should be treated with amifampridine base tablets.

LEARNING ENVIROMENTS

Clinical Placements Overview

First Year: Integrated Principles of Clinical Care Module Placement (12h)

Aim: Professional Orientation

Sessions: 2 days, one sessions per semester (community and hospital)

Second Year: Cardiovascular & Renal Module Placement (30h)

Aim: Safe dispensing; maintaining error logs; CPD entries

Sessions: 4 whole days. (community and hospital)

Third Year: Gastrointestinal & Skin Module Placement (24h)

Aim: Consult to undertake Meds Reconciliation, MUR, NMS, Responding to symptoms

Sessions: Continuous block in GSS module. (community & hospital)

Shadowing

Product quality &basic advice

Patient interaction& problem

solving

Moving from patients withuni-system to multi-system disease

Transition point: Pharmacy student to student pharmacist

Clinical Placements Overview

Third Year: Endocrine Systems and Cancer Placements (48h)

Aim: Medicines optimisation for long term conditions – care planning, prioritisation and evidence base medicine

Sessions: Sessional (4 hr) experiences to represent a minimum of 12 sessions in hospital sectors.

Fourth Year: Science, Practice & Complex Decision Making Placements (40h)

Aim: Medicines optimisation in complex patients

Sessions: Integrated working alongside senior pharmacist for 40 h period (spread over 2 weeks) in complex patients/diseases in community (anticoagulation, diabetes, hypertension etc) or hospital (mental health, oncology, renal, HIV).

Problem Solving – care planning

Supervised care delivery

Moving from patients with multi-system disease to more specialised therapies

– treating outside guidelines

Research Programme - Final Year Programme

THE MPHARM PROGRAMME AT KING’S COLLEGE LONDON

QUESTIONS?

Professor Graham DaviesProgramme Director